Research progress in overcoming ibrutinib drug resistance

Ma, X.-Y., Zhao, M., Li, Y.-D., Chen, Y., Wei, L., & Chen, Z.-S. (2022). Research progress in overcoming ibrutinib drug resistance. Drugs of Today, 58(2), 85–94. https://doi.org/10.1358/dot.2022.58.2.3360405
Authors:
Xiang-Yu Ma
Min Zhao
Yi-Dong Li
Yanglu Chen
Liuya Wei
Zhe-Sheng Chen
Affiliated Authors:
Yanglu Chen
Columbia Affiliation:
Subjects:
Antineoplastic Agents (MeSH)
Leukemia, Lymphocytic, Chronic, B-Cell (MeSH)
Author Keywords:
anticancer therapy
b-cell malignancies
bruton tyrosine kinase (btk) inhibitors
drug resistance
ibrutinib
small-molecule inhibitors
elink
Publication Type:
Article
Unique ID:
10.1358/dot.2022.58.2.3360405
PMID:
35188143
DOI:
10.1358/dot.2022.58.2.3360405
Journal:
Drugs of Today (Barcelona, Spain: 1998)
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: